The U.S. Securities and Exchange Commission has asked Pfizer for information about two of its painkillers, Celebrex and Bextra, the Associated Press reported this week.
The company wouldn't elaborate, except to say it is cooperating with the request, which was made in the second quarter of this year, the wire service said.
Insider is waiting for your emails!
No comments:
Post a Comment